INTERNATIONAL SEMINAR ON HUMAN GENOMIC ENHANCEMENT AND PUBLIC HEALTH: A COLLECTIVIST PUBLIC HEALTH FRAMEWORK
Talks at this conferenceAdd a talk
HUMAN GENOMIC ENHANCEMENT:
A COLLECTIVIST PUBLIC HEALTH FRAMEWORK
To bring to the national academic scene an innovative approach on the internationally relevant topic of human genome enhancement and its relation to the field of public health, which has been developed in one of the world's great research centres (The Oxford Uehiro Centre for Practical Ethics, University of Oxford): Collectivist Public Health framework, a proposal for an ethical analysis of collectively oriented human genome enhancement technologies, supported by the so-called public health ethics.
- To introduce the participants to the topic of human genome enhancement.
- To identify and address the ethical and political issues surrounding human genome enhancement technologies.
- Analyze the distinction between therapy and enhancement.
- To discuss the relevance of this distinction for the promotion of public/collective goods in the field of public health.
- Articulate the knowledge discussed and consolidate your understanding through analysis of selected cases.
CALLFOR REGISTRANTIONSLink: https://docs.google.com/forms/d/e/1FAIpQLSdscIfq7Vju0wOLxy9MQYjxWZXpZFbKtBuDtBiZUbAiqZVw9Q/viewform QR CODE:
§Four-day event with two-hour daily: 10am to 12pm (Brazilian Official Time).
§Registered participants with attendance over 75% will receive certificates.
§Free event (financed with public resources) and with limited registrations (90 participants). Please kindly check schedule availability before registering.
§Registrants will receive three texts kindly sent to them by Tess Johnson (DPhil). The purpose is that the previous reading optimizes the discussion that will follow from the lecture presented.
§The lectures and discussion will be translated simultaneously: English – Portuguese.
§Contact email (for further information): [email protected]
Day 1 – March 20th (Monday)
A background on the development of human enhancement and how this 0has led to the potential use of human germline genome editing for enhancement in the near future. A summary of the key ethical issues as identified in the early debate would be included.
Day 2 – March 21st (Tuesday)
A background on issues with contrasting human enhancement and therapeutic uses of these technologies, with reference to the treatment-enhancement distinction and how it does not apply in the public health setting (especially when it comes to, eg. vaccination and contraception as public health initiatives). This would include discussion of how public health ethics takes a collectivist viewpoint and how this intersects with denying the treatment-enhancement distinction.
Day 3 – March 23rd (Thursday)
A proposal for how we might take a public health ethics approach to human enhancement and how this can help with:
a) The effective identification of stakeholders and their interests that might be affected by policy on using enhancement Technologies.
b) The effective identification of ethical concepts that are useful tools for weighing interests against each other in deciding whether to use or how to regulate human enhancement technologies.
c) Thorough-going discussion of justice issues, particularly considering context-specific implementation of human enhancement technologies around the world, given varying levels of capacity for implementation, values surrounding traits that should be enhanced, etc.
Day 4 – March 24th (Friday)